The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health reveals how genetic changes in the parasite responsible for one of the world’s most common sexually transmitted ...

During a live event, Jahan Aghalar, MD, discussed the efficacy and safety of darolutamide plus ADT in mHSPC in the ARANOTE ...

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that three ...

Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

The buying on the counter came after the company announced in a latest exchange filing that its clinical-stage biotech division, Sathgen Therapeutics, was granted a patent by the China National ...

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate ...

Discover a study comparing pelvic floor therapies that reveals magnetic stimulation may significantly improve recovery from ...

Lantheus remains strong with PYLARIFY growth, Alzheimer’s potential, and solid financials despite stock volatility and risks.

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

In the two decades since the first robotic surgery was performed in Australia, both the computers that drive them and the ...